Kalpana Gupta Shekhawat: The Neurobiology of Elevated Homocysteine
Kalpana Gupta Shekhawat, Chairperson at the Functional and Metabolic Medicine Academy, Gurugram, India, shared a post on LinkedIn:
”The Neurobiology of Elevated Homocysteine
Brain health is influenced by far more than genetics and ageing.
Nutrient status, vascular function, inflammation, mitochondrial health, and methylation all play critical roles in maintaining normal neurological function.
Among the laboratory markers that reflect these interconnected processes, homocysteine provides valuable clinical insight.
Homocysteine is an intermediate amino acid formed during methionine metabolism.
Under normal circumstances, it is efficiently recycled through methylation or converted into cysteine with the help of folate, vitamin B12, vitamin B6, and riboflavin.
When these pathways become inefficient, homocysteine accumulates, reflecting impaired methylation and broader metabolic dysfunction.
From a functional medicine perspective, an elevated homocysteine level is more than an abnormal laboratory finding—it is an important clinical signal.
Rather than asking how to lower the value, the more meaningful question is:
What is driving it?
A growing body of research has shown that elevated homocysteine can adversely affect the brain through multiple mechanisms.
It promotes excitotoxicity by overstimulating NMDA receptors, increases oxidative stress, impairs mitochondrial function, damages the vascular endothelium, and disrupts the integrity of the blood–brain barrier.
It also contributes to persistent neuroinflammation, creating an environment that may accelerate cognitive decline and increase the risk of stroke, vascular dementia, depression, and other neurological disorders.
Importantly, elevated homocysteine should not be attributed solely to MTHFR variants.
Nutritional deficiencies, chronic inflammation, hypothyroidism, renal dysfunction, certain medications, excessive alcohol intake, and poor dietary patterns can all impair homocysteine metabolism.
Identifying these contributors is essential for developing an effective treatment strategy.
For clinicians, homocysteine offers an opportunity to identify metabolic dysfunction before more significant neurological consequences develop.
Evaluating nutritional status, supporting methylation, reducing inflammation, and optimizing lifestyle factors can improve homocysteine metabolism while addressing the underlying cause.
Rather than viewing homocysteine as an isolated laboratory value, it should be considered within the broader context of metabolic health, where it can provide meaningful insights into brain function, cognitive resilience, and long-term neurological outcomes.”
Stay updated with Hemostasis Today.
-
Nov 3, 2026, 02:21Digambar Panchal: NGS Demonstrates Key Role in Solving Challenging Hematology Cases at LTMGH
-
Nov 3, 2026, 02:07David Smadja: Does Immediate Breast Reconstruction Increase the Risk of Thrombosis and Bleeding after a Mastectomy?
-
Nov 3, 2026, 01:57Nour Al-Mozain: What Does a Bathtub Have to Do with Hemoglobin S?
-
Nov 3, 2026, 01:51Cesar de Almeida Neto: Highlighting The Final Day of Hemo 2026
-
Nov 3, 2026, 01:34Jae Hyun Byun: Beyond Stenosis Understanding Carotid Plaque Instability
-
Nov 3, 2026, 01:20Smriti Yadav: A New Milestone in Transfusion Medicine
-
Nov 3, 2026, 00:55Dušan Ušjak: A Month of Research and Scientific Collaboration
-
Nov 3, 2026, 00:27Grace Gorecki: Early IVIG Accelerates Platelet Recovery in HIT
-
Nov 2, 2026, 22:15Micheline Mambue: A Case of Early Stent Thrombosis Successfully Managed With Repeat Angioplasty